Session

The pivotal role of the nurse in managing mCRPC: Collaborating to improve patient care

EAUN Industry Session by BAYER

  • Location:
    Room 5
  • Chair:
     L. Drudge-Coates, London (GB)
  • Aims and objectives of this session

    Describe the incidence and impact of metastatic castration-resistant prostate cancer (mCRPC) and the opportunities for specialist nurses to improve patient care and outcomes

    ·Follow the patient journey through mCRPC and identify key opportunities for nurses to enhance collaborative multidisciplinary care

    · Describe strategies for nurses to provide patient and caregiver education and promote adherence to current treatments including a novel radiopharmaceutical

    Key learning objectives
    At the end of this session delegates should be able to:
    1. Describe the incidence and impact of mCRPC.
    2. Understand ongoing unmet patient needs in mCRPC, including the effects of bone metastases and skeletal-related events.
    3. Discuss the evolving role of the specialist nurse and recognise opportunities to improve patient care and outcomes.

The impact of mCRPC and the evolving role of the specialist nurse
 
 L. Drudge-Coates, London (GB)
The patient journey in mCRPC: Key touch points for nurses
 
 B. Tombal, Brussels (BE)
 
 C. Remacle, Brussels (BE)
Strategies for effective patient education and adherence
 
 M. Nematollahi, Ontario (CA)
Questions from the floor